LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in NVS — Novartis AG
CIK 932974
BOSTON, MA
Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,867,632
+$798,688 QoQ
Shares Held
11,917
+70.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#448
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $220,949,345 across 14 Drug Manufacturers - General names. NVS ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
59,780 | $71,701,930 | |
| 2 | JNJ |
Johnson & Johnson
|
252,775 | $64,197,266 | |
| 3 | MRK |
Merck & Co., Inc.
|
332,735 | $42,756,447 | |
| 4 | AMGN |
Amgen Inc
|
50,038 | $18,119,760 | |
| 5 | ABBV |
AbbVie Inc.
|
61,527 | $15,482,654 | |
| 6 | NVS |
Novartis AG
This page
|
11,917 | $1,867,632 | |
| 7 | NVO |
Novo Nordisk A S
|
36,192 | $1,735,044 | |
| 8 | PFE |
Pfizer Inc
|
56,816 | $1,368,129 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,867,632 | 11,917 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,068,944 | 6,998 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $961,781 | 6,976 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $840,100 | 6,551 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $792,736 | 6,551 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $730,305 | 6,551 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $670,563 | 6,891 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $862,189 | 7,496 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $798,024 | 7,496 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $686,396 | 7,096 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $788,676 | 7,811 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $795,628 | 7,811 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $832,002 | 8,245 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $816,040 | 8,870 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $911,282 | 10,045 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $763,520 | 10,045 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $925,011 | 10,943 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,046,243 | 11,923 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $1,038,531 | 11,873 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,147,046 | 14,026 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,438,033 | 15,761 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,330,410 | 15,564 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,839,874 | 19,484 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $1,831,203 | 21,058 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,909,077 | 21,858 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,722,050 | 20,886 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||